Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Intermolecular Inc    IMI

INTERMOLECULAR INC

(IMI)
SummaryQuotesNewsCalendarCompany 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Intermolecular : Merck Completes Acquisition of Intermolecular

share with twitter share with LinkedIn share with facebook
share via e-mail
09/23/2019 | 04:35am EST

Merck, a leading science and technology company, today announced the completion of its acquisition of Intermolecular, Inc., a California-based company for advanced materials innovation.

The transaction creates a strong solutions provider in the electronic materials industry positioned to drive the development of next-generation digital devices and technologies.

'Today is a very special day for us as we successfully complete the acquisition and welcome Intermolecular to Merck. For three and a half centuries, we have been dedicated to advancing science and technology for the benefit of human progress. I am glad that Intermolecular shares this spirit. Together we are well-positioned to drive and accelerate future innovations in the electronic materials industry,' said Kai Beckmann, member of the Executive Board of Merck and CEO Performance Materials.

The closing follows the satisfaction of regulatory clearances and other customary closing conditions. Upon closing, approximately 90 employees at Intermolecular's Research & Development site in San Jose, California, USA will become part of the Performance Materials business sector of Merck.

On May 6, 2019, Merck signed a definitive agreement to acquire Intermolecular through a subsidiary for US$1.20 per share in an all-cash transaction, representing an equity value of approximately US$ 62 million.

Intermolecular possesses application-specific materials expertise as well as accelerated learning and experimentation platforms with a powerful analytics infrastructure that complement the business and technology portfolio of Merck. Intermolecular's fabrication and testing capabilities allow material combinations to be tested directly within the specific target application. In comparison with conventional methods, these capabilities translate to major time reductions in the development process, dramatically accelerated learning cycles and insights into novel material systems to provide customers with unique service value.

Merck has also achieved another important milestone in its strategic 'Bright Future' transformation program. On September 16, 2019, Versum Materials Inc. and Merck received notice from the Committee on Foreign Investment in the United States ('CFIUS') stating that CFIUS has completed its review of the proposed acquisition of Versum by Merck and has concluded that there are no unresolved national security concerns with respect to the transaction. The parties continue to work toward closing in the second half of 2019, subject to receipt of antitrust approval in China and the satisfaction of other customary closing conditions. On April 12, 2019, Merck signed a definitive agreement to acquire Versum Materials, one of the world's leading suppliers of innovation-driven, high-purity process chemicals, gases and equipment for semiconductor manufacturing, for US$53 per share in cash.

Contact:

Gangolf Schrimpf

Tel: +49 6151 72-9591

About Merck

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices - the company is everywhere. In 2018, Merck generated sales of EUR 14.8 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, Millipore Sigma in life science, and EMD Performance Materials.

(C) 2019 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on INTERMOLECULAR INC
2019INTERMOLECULAR : Merck Completes Acquisition of Intermolecular
AQ
2019INTERMOLECULAR INC : Completion of Acquisition or Disposition of Assets, Notice ..
AQ
2019INTERMOLECULAR : 2Q Earnings Snapshot
AQ
2019INTERMOLECULAR : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2019INTERMOLECULAR INC : Results of Operations and Financial Condition, Financial St..
AQ
2019INTERMOLECULAR : Reports Second Quarter 2019 Financial Results
PR
2019INTERMOLECULAR TO LEAD SESSION ON 3D : Current Implementations and Future Trends..
PR
2019Intermolecular Stockholders Agree to Merck KGaA Acquisition
DJ
2019INTERMOLECULAR INC : Submission of Matters to a Vote of Security Holders, Other ..
AQ
2019INTERMOLECULAR : Stockholders Approve Merck KGaA, Darmstadt, Germany's Proposed ..
PR
More news
Chart INTERMOLECULAR INC
Duration : Period :
Intermolecular Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Casper van Oosten President & Chief Executive Officer
Milind Weling Senior Vice President-Programs & Operations
Bill Roeschlein Chief Financial Officer & Senior Vice President
Karl Littau Chief Technology Officer
Luiz Vieira Director
Sector and Competitors
1st jan.Capitalization (M$)
INTERMOLECULAR INC18.32%59
INTEL CORPORATION12.13%287 029
TAIWAN SEMICONDUCTOR MFG. CO. LTD.--.--%280 637
NVIDIA CORPORATION33.74%192 596
BROADCOM INC.-0.10%126 105
TEXAS INSTRUMENTS2.30%124 081